Concepedia

ACC inhibitor alone or co-administered with a DGAT2 inhibitor in patients with non-alcoholic fatty liver disease: two parallel, placebo-controlled, randomized phase 2a trials

Roberto A. Calle, Neeta B. Amin, Santos Carvajal‐Gonzalez, Trenton T. Ross, Arthur Bergman, Sudeepta Aggarwal, Collin Crowley, Anthony Rinaldi, Jessica Mancuso, Naresh Aggarwal,

Nature Medicine · 2021 · 219 citations · 38 references

DOI

Concepts

References

38

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

Journal of Hepatology · 2016 · 4.8K citations

, , +9

Nonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions

Elizabeth M. Brunt, Christine G. Janney, Adrian M. Di Bisceglie et al. · The American Journal of Gastroenterology · 1999 · 3.9K citations

, , +17

The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study

Leon A. Adams, James Lymp, Jenny St. Sauver et al. · Gastroenterology · 2005 · 2.9K citations · Full text

, , +15

Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up

Mattias Ekstedt, Hannes Hagström, Patrik Nasr et al. · Hepatology · 2014 · 2.3K citations · Full text

, , +17

Increased De Novo Lipogenesis Is a Distinct Characteristic of Individuals With Nonalcoholic Fatty Liver Disease

Jennifer E. Lambert, María A. Ramos-Román, Jeffrey D. Browning et al. · Gastroenterology · 2013 · 1.1K citations · Full text

, , +11